The authors found that in endometrial and EOC BMs, the expression of alpha-enolase (ENO1) and triosephosphate isomerase (TPI-1) was higher and the expression of Transgelin-2 (TAGLN2) was lower compared to primary cancers, suggesting a role in development and progression of BMs. Here, TAGLN2 is linked to cancer.